deaths from glp-1 Cardiovascular and mortality outcomes with receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia GLP-1 medications found to reduce

GLP-1 production increases feeling of satiety by: slowing gastric emptying feel fuller, faster & longer suppressing appetite receptors in brain less hunger & cravings GLP-1 cells in the small intestine regulate carbohydrate metabolism through: increasing insulin production regulates blood glucose suppressing glucagon release Ideal Candidates GLP-1 medications have been successfully used for obese patients (BMI greater than or equal to 30) and for overweight patients (BMI greater than or equal to 27) who also have other health conditions contributing to weight

Withdrawal of Approval of 92 New Drug Applications and 49 Abbreviated New Drug Applications (2009)

An increased intake of dietary fiber may improve the likelihood that a child will be able to discontinue laxative therapies

Tennis players battling through matches in the heat benefit from rapid hydration with balanced electrolytes

Anti-inflammatory Effects BPC-157 modulates inflammatory signaling, helping reduce excessive inflammation that may delay healing. 4